Analysis of Aurora kinase A expression in CD34(+) blast cells isolated from patients with myelodysplastic syndromes and acute myeloid leukemia - Wikidata - wikimedia - TriplyDB

Analysis of Aurora kinase A expression in CD34(+) blast cells isolated from patients with myelodysplastic syndromes and acute myeloid leukemia

Analysis of Aurora kinase A expression in CD34(+) blast cells isolated from patients with myelodysplastic syndromes and acute myeloid leukemia

http://www.wikidata.org/entity/Q37269040

about

A phase I trial of the aurora kinase inhibitor, ENMD-2076, in patients with relapsed or refractory acute myeloid leukemia or chronic myelomonocytic leukemia.Phase I study of MLN8237--investigational Aurora A kinase inhibitor--in relapsed/refractory multiple myeloma, non-Hodgkin lymphoma and chronic lymphocytic leukemia.A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma The aurora kinases in cell cycle and leukemia Cell cycle control in acute myeloid leukemia.Aurora A kinase expression is increased in leukemia stem cells, and a selective Aurora A kinase inhibitor enhances Ara-C-induced apoptosis in acute myeloid leukemia stem cells.Aurora-B expression may not contribute to disease progression: a reflection of the heterogeneous pathogenesis?New drugs for chronic myelogenous leukemia.ENMD-2076 for hematological malignancies.Targeting of polo-like kinases and their cross talk with Aurora kinases--possible therapeutic strategies in human acute myeloid leukemia?Aurora kinase inhibitor patents and agents in clinical testing: an update (2011 - 2013).Therapeutic targeting the cell division cycle 25 (CDC25) phosphatases in human acute myeloid leukemia--the possibility to target several kinases through inhibition of the various CDC25 isoforms.Dose selection for the investigational anticancer agent alisertib (MLN8237): Pharmacokinetics, pharmacodynamics, and exposure-safety relationships.Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target.MYCN contributes to the malignant characteristics of erythroleukemia through EZH2-mediated epigenetic repression of p21.Plant-derived flavones as inhibitors of aurora B kinase and their quantitative structure-activity relationships.Concurrent Inhibition of Neurosphere and Monolayer Cells of Pediatric Glioblastoma by Aurora A Inhibitor MLN8237 Predicted Survival Extension in PDOX models.Specific immune responses against epitopes derived from Aurora kinase A and B in acute myeloid leukemia.Phase 1 study of the investigational Aurora A kinase inhibitor alisertib (MLN8237) in East Asian cancer patients: pharmacokinetics and recommended phase 2 dose.

P2860

Q33167422-F50F89D8-31F1-4480-B75E-555F179406FF Q33412196-4890C5F8-3BF6-4965-B065-5F2AFDB51C43 Q33944281-2A35A959-B948-47EB-ABEC-37EDB7F40D8B Q34203062-98DC9591-0A64-4E31-A9C5-CB297177EEC8 Q36206479-F8DC178D-2784-4E44-8A08-C086C612A5F3 Q36297651-933C1071-94BC-481D-9022-354C9F16B8E4 Q36366919-22EA0A2B-81FF-424F-8B59-4917BAA34BBC Q37843769-A52934BB-6D9B-41AC-B9B2-1D4234B440E3 Q37991379-85A20881-0D4D-4AEF-B1BD-06AC5F159007 Q37994256-EC32FE29-CFB1-44CC-8AD3-B3453B3716FE Q38223271-E9C62EAF-D40C-48F0-BC08-25DBDD54A18E Q38268221-A8AB5D8F-94BF-466D-B85E-EEC7A58E9DDC Q39115623-ABAB6046-4E0A-4804-9AA3-E6130D71E0A8 Q41368368-E468B9DE-B8B9-498E-B97B-10B682EF7384 Q45742884-EAB2AD50-3598-493A-B921-4C7B879FDBF3 Q46827793-E2F27758-5E25-46A1-BA96-03C3A6D62602 Q49791882-C717366D-4A44-41C5-99B6-7481A7A926A8 Q54475024-88B5BF95-CA0F-4294-BFBC-18CE099C6D4F Q55056081-C1AB5BB4-6ADA-4677-ABCA-1817C04C5283

P2860

Analysis of Aurora kinase A expression in CD34(+) blast cells isolated from patients with myelodysplastic syndromes and acute myeloid leukemia

http://www.wikidata.org/entity/Q37269040

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Analysis of Aurora kinase A expression in CD34

@nl

Analysis of Aurora kinase A ex ...... mes and acute myeloid leukemia

@en

type

label

Analysis of Aurora kinase A expression in CD34

@nl

Analysis of Aurora kinase A ex ...... mes and acute myeloid leukemia

@en

prefLabel

Analysis of Aurora kinase A expression in CD34

@nl

Analysis of Aurora kinase A ex ...... mes and acute myeloid leukemia

@en

P1433

Q37269040-C4801404-CB97-4C16-9B11-8EC8F3976986

P1476

Q37269040-41C1450F-8D0B-4D30-A567-568EB6D42ED8

P2093

Q37269040-2238919A-2DA6-4D41-903E-4A15089BD6B0

Q37269040-2E78B941-1AE2-42A6-97CE-59A3F27E7BE8

Q37269040-56689F99-41BB-400E-883A-C6FF4AE4851B

Q37269040-61EFA0B3-1FEA-4347-968C-9376BEB252B4

Q37269040-82D6876B-CA90-4F43-A739-A2B3710FBEE1

Q37269040-9CA917D8-D4B0-44D0-AF75-8AF82C3D106B

Q37269040-DE526A5D-A9EF-4D77-B733-31564CC1E51D

P2860

Q37269040-0B2B51CC-5755-4E02-8149-2F73B24993D4

Q37269040-191E8957-7566-4A52-8BAC-205F23ED8EB2

Q37269040-399991A6-C187-4D17-8F03-AD2174230B36

Q37269040-5486EFC1-76CB-4DFC-BDB2-0AC36D5A45B4

Q37269040-548ED9B2-A477-43DC-A544-2FFCD0075E74

Q37269040-6C0BD733-1094-4481-9320-B5A417C3B6D7

Q37269040-79C15F7B-2E25-4F8F-81D4-1280CD011FF5

Q37269040-88F4DCFD-7821-4428-B1E2-04DB10C471CD

Q37269040-8BEEB47C-CFA5-49A0-95A5-1E69FB27BE21

Q37269040-A3339F4F-7FE7-40B9-AF07-07C772A48004

P2888

Q37269040-1C082A26-22C8-42DB-A16E-E0AAD64B5F5F

P304

Q37269040-B422669A-AEE7-495B-8874-EF8738E4A3C0

P31

Q37269040-FDAB2909-1C71-4AF8-819C-C3A645A67899

P356

Q37269040-3EC1BE8A-F903-40E4-AC9A-EA19F85CD960

P433

Q37269040-6A06BA3E-9FB0-4EC8-9DF7-8CA234DB22E4

P478

Q37269040-F1EB907D-63F0-4C66-87B5-F542A23ECC2A

P50

Q37269040-4C394B24-45CC-406C-8865-3F6AFE3441A1

Q37269040-CD212B04-C099-4470-9541-6DD48BF98FEF

P577

Q37269040-AE5AE5A3-195A-4BC9-8154-1F48332B7F91

P5875

Q37269040-2268B902-9DD3-4FE9-A3EC-EAC9E2F8BA44

P698

Q37269040-CB676F3F-E447-4BDF-BDEF-74BD8F94FC1D

P932

Q37269040-066895D3-2E21-419F-9EFE-195A86BFF599

P356

S12308-008-0019-3

P1433

Journal of hematopathology

P1476

Analysis of Aurora kinase A ex ...... mes and acute myeloid leukemia

@en

P2093

Carlos E Bueso-Ramos

http://www.w3.org/2001/XMLSchema#string

Dongjiu Ye

http://www.w3.org/2001/XMLSchema#string

L Jeffrey Medeiros

http://www.w3.org/2001/XMLSchema#string

Lianchun Xiao

http://www.w3.org/2001/XMLSchema#string

Martin H Nguyen

http://www.w3.org/2001/XMLSchema#string

Michael H Fernandez

http://www.w3.org/2001/XMLSchema#string

Saroj Vadhan-Raj

http://www.w3.org/2001/XMLSchema#string

P2860

Chromosomal passengers and the (aurora) ABCs of mitosis

Direct association with inner centromere protein (INCENP) activates the novel chromosomal passenger protein, Aurora-C

International scoring system for evaluating prognosis in myelodysplastic syndromes

Aurora B expression directly correlates with prostate cancer malignancy and influence prostate cell proliferation.

Myelodysplasia.

Aurora-A - a guardian of poles.

Aurora kinases: shining lights on the therapeutic horizon?

Myelodysplastic syndromes: the complexity of stem-cell diseases.

Overexpression of the centrosomal protein Aurora-A kinase is associated with poor prognosis in epithelial ovarian cancer patients.

Dysplasia and high proliferation rate are common in acute myeloid leukemia with inv(16)(p13q22).

P2888

s12308-008-0019-3

P304

2-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12308-008-0019-3

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Hagop Kantarjian

Guillermo Garcia-Manero

P577

2008-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26730785

http://www.w3.org/2001/XMLSchema#string

P698

19669217

http://www.w3.org/2001/XMLSchema#string

P932

2713495

http://www.w3.org/2001/XMLSchema#string